Welcome to ASENT
The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders.
Our primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
19th Annual Meeting Highlights
Thank you for attending the 19th Annual American Society of Neurotherapeutics (ASENT) Meeting at the Hilton Washington DC/Rockville Hotel and Executive Meeting Center in Rockville, Maryland.
The Pipeline Session is unique to ASENT. Twenty-five (25) presentations were heard about the discovery and development of new CNS therapy candidates. Sessions addressed Alzheimer’s disease, big data, neuromodulation, drug repurposing, regulatory processes for dose determination and prescribing, rapidly-acting antidepressants, pharmacogenetics, the placebo eff ect, and a special session on Parkinson’s disease honoring Stan Fahn, MD, Columbia University, an ASENT founder.